Consumer & Travel Stock News
Monday, October 12, 2026
Iovance Reports 41% Response Rate for Lifileucel in Melanoma Trial
Iovance Biotherapeutics reported positive interim results from its Phase 2 IOV-COM-202 study of lifileucel, a tumor-infiltrating lymphocyte (TIL) therapy, in...
Johnson & Johnson Q3 2026 Earnings Preview: What Analysts Expect on October 13, 2026
Consensus estimates for Johnson & Johnson's third quarter of 2026 call for revenue of $25.40 billion and adjusted EPS of $2.66, as the stock trades near...
Amazon in Talks to Acquire AI Startup Decart for Around $7 Billion
Amazon is reportedly in discussions to acquire San Francisco-based AI startup Decart in a deal that could be valued at around $7 billion. Decart makes software...
Disney's ABC News Faces DOJ Antitrust Probe Over White House Coverage Halt
The U.S. Department of Justice (DOJ) is investigating The Walt Disney Company's ABC News division, CBS, CNN, Fox News and NBC for potential antitrust...
Merck’s Experimental Eye Drug Meets Trial Goal, but Raises Safety Concerns
Duolingo CEO Sells $16.7 Million in Shares Under Trading Plan
Tata Motors Raises Iveco Offer to €14.40 Amid Approval Delays
Iovance's Melanoma Therapy Shows Promise and Revenue Surges — But Can This Cash-Burning Biotech Reach Profitability Before the Money Runs Out?
Other News
Eli Lilly Reports Positive Taltz-Zepbound Combo Results for Psoriasis, Obesity
Monster Beverage Price Target Cut From $95 to $52
Southwest Considers Boeing 787s for Long-Haul Expansion
Novo Nordisk Loses Key Patent, Facing Ozempic and Wegovy Generics by 2031
Amazon Faces Possible Grid Cuts in Mississippi During Peak Demand
Volkswagen Unveils Electric ID. Tiguan to Replace ID.4 and ID.5
Ryanair warns fares could stay high into 2028 amid Iran conflict
Pyxis Oncology Sees GordonMD Raise Stake to Nearly 28 Million Shares
Abivax Draws 12 Buy Ratings as Analysts See 84% Upside
Carrefour Sells 35 Store Properties, Explores Codifrance Purchase
Retension Prices $45 Million IPO; Blueprint Plans 229 Layoffs
Harmony Biosciences Shares Fall on Profit-Taking After Pediatric WAKIX Approval
EU and China Reach Initial Trade Deal on Autos
Amazon Issues 100-Year Bonds as BNP Forecasts 43%-45% AWS Revenue Growth
STEX Receives Nasdaq Notice for Falling Below Minimum Bid Price Requirement
Roche Wins FDA Nod for Tecentriq in Stage III dMMR Colon Cancer
Live Nation Announces Pricing of $730M and €600M Senior Notes Due 2032
MBRX Shareholders Approve Potential Reverse Stock Split and Increased Equity Plan Shares
Boot Barn Hits 52-Week Low as Same-Store Sales Slow
JPMorgan Bets Big on Definium's Brain Drug — But Can a Small Biotech Really Double From Here?
HCW Biologics Gets FDA Roadmap for Cancer Drug — But Can a $25 Million Company Survive the Journey to the Clinic?
Euro Hits 17-Month Low on French Debt Concerns